Funder: American Cancer Society
Due Dates: Rolling | June 1, 2025 (for July review/start Sept 2025) | After June 1, 2025 (for December review/start April 2026)
Funding Amounts: Up to $75,000 total costs for a 1-year project; indirect costs not allowed.
Summary: Supports key experiments to advance ongoing cancer research projects toward commercialization, with a focus on technology validation and de-risking.
Key Information: Proposals must be commercially driven and not for new research directions; awardees join a commercialization-focused learning community.